Sera and bronchoalveolar lavage fluid (BALF) taken prior to chemotherapy from patients diagnosed with non-small cell lung cancer (NSCLC) were analyzed by enzyme linked immunosorbent assay (ELISA) to assess circulating levels of IL-27, IL-29, IL-31, and IL-33. Here, IL33 is linked to non-small cell lung carcinoma.